MetaCap

Eikon Therapeutics SEC Filings

NASDAQ: EIKNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

4.74-0.02 (-0.42%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Eikon Therapeutics filing overview

This page lists 42 recent SEC filings by Eikon Therapeutics (EIKN), including 14 4, 11 8-K, 6 SCHEDULE 13G, 3 10-Q. The latest annual report (10-K) was filed on Mar 30, 2026 for the period ending Dec 31, 2025. The most recent quarterly report (10-Q) was filed on Nov 12, 2026.

The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Nov 12, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

EIKN SEC filings

Eikon Therapeutics SEC filings
FiledFormDescriptionDocument
Nov 12, 20268-KResults of Operations and Financial ConditionView on EDGAR
Nov 12, 202610-QQuarterly reportView on EDGAR
Oct 26, 20268-KRegulation FD Disclosure; Other EventsView on EDGAR
Oct 23, 20268-KRegulation FD Disclosure; Other EventsView on EDGAR
Oct 7, 2026SCHEDULE 13G/ABeneficial ownership report (passive) (amendment)View on EDGAR
Oct 2, 2026SCHEDULE 13G/ABeneficial ownership report (passive) (amendment)View on EDGAR
Sep 8, 20264Statement of changes in beneficial ownershipView on EDGAR
Aug 14, 20268-KRegulation FD DisclosureView on EDGAR
Aug 13, 20268-KResults of Operations and Financial ConditionView on EDGAR
Aug 13, 202610-QQuarterly reportView on EDGAR
Aug 6, 2026SCHEDULE 13G/ABeneficial ownership report (passive) (amendment)View on EDGAR
Aug 3, 20268-KDeparture or Appointment of Directors or Officers; Compensatory ArrangementsView on EDGAR
Jun 10, 20268-KDeparture or Appointment of Directors or Officers; Compensatory ArrangementsView on EDGAR
Jun 1, 20268-KRegulation FD Disclosure; Other EventsView on EDGAR
May 15, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
May 13, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
May 11, 20268-KResults of Operations and Financial Condition; Regulation FD DisclosureView on EDGAR
May 11, 202610-QQuarterly reportView on EDGAR
May 6, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
Apr 29, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
Mar 30, 202610-KAnnual reportView on EDGAR
Mar 30, 20268-KResults of Operations and Financial ConditionView on EDGAR
Mar 4, 20264Statement of changes in beneficial ownershipView on EDGAR
Mar 4, 20264Statement of changes in beneficial ownershipView on EDGAR
Mar 4, 20264Statement of changes in beneficial ownershipView on EDGAR
Mar 4, 20264Statement of changes in beneficial ownershipView on EDGAR
Mar 4, 20264Statement of changes in beneficial ownershipView on EDGAR
Mar 4, 20264Statement of changes in beneficial ownershipView on EDGAR
Mar 4, 20264Statement of changes in beneficial ownershipView on EDGAR
Feb 18, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
Feb 12, 2026SCHEDULE 13DBeneficial ownership report (activist)View on EDGAR
Feb 11, 2026SCHEDULE 13GBeneficial ownership report (passive)View on EDGAR
Feb 10, 20264Statement of changes in beneficial ownershipView on EDGAR
Feb 9, 20264Statement of changes in beneficial ownershipView on EDGAR
Feb 6, 20264OWNERSHIP DOCUMENTView on EDGAR
Feb 6, 20268-KAmendments to Articles of Incorporation or Bylaws; Change in Fiscal YearView on EDGAR
Feb 6, 20264Statement of changes in beneficial ownershipView on EDGAR
Feb 6, 20264Statement of changes in beneficial ownershipView on EDGAR
Feb 6, 20264Statement of changes in beneficial ownershipView on EDGAR
Feb 5, 2026424B4ProspectusView on EDGAR
Jan 28, 2026S-1/ARegistration statement (amendment)View on EDGAR
Jan 9, 2026S-1Registration statementView on EDGAR

Related